 |
 |
Grand Slam Asset Management rejects Sun Pharma’s sweetened offer for Taro
14 August 2012
|
|
|
|
Sun Pharma to buy out Israel’s Taro for $571 million
13 August 2012
|
|
|
Sun Pharma to spin off domestic formulations business into Sun Resins & Polymers
11 August 2012
|
| | |
|
|
Sun Pharmaceuticals eyes German generic-drug maker Stada: report
03 August 2012
|
|
|
Israel’s Taro rejects Sun Pharma’s $367-mn buyout offer
20 July 2012
|
|
|
Shanghvi steps down as Sun Pharma chairman; Israel Makov to take over
30 May 2012
|
|
|
Dr. Reddy’s, Sun Pharma, 9 others get FDA nod for generic version of Plavix
19 May 2012
|
|
|
Sun Pharma to buy remaining stake in Israeli unit Taro for Rs1,810 crore
19 October 2011
|
|
|
Sun Pharma resolves FDA issue at US plant
19 September 2011
|
|
|
Sun to co market Merck's Diabetes drugs in India
25 April 2011
|
|
|
Merck, Sun Pharma in generics JV
11 April 2011
|
|
|
US FDA grants tentative approval for Sun's generic Aricept
30 November 2010
|
|
|
Sun Pharma receives tentative USFDA approval for generic Crestor
30 September 2010
|
|
|
Sun Pharma board approves stock split into Re1 shares
24 September 2010
|
|
|
Sun acquires controlling stake in Taro, Shanghvi is chairman
22 September 2010
|
|
|
Israel Supreme Court lifts injunction on Sun's acquisition of Taro
08 September 2010
|
|
|
USFDA approves Sun's generic version of Lilly's Strattera
01 September 2010
|
|
|
US court favours Sun Pharma over Eli Lilly’s cancer drug patent on
29 July 2010
|
|
|
Taro mulls next move after dismissal of US suit against Sun Pharma
17 July 2010
|
|
|
Sun Pharma announces US FDA approval for generic Flomax
16 July 2010
|
|
|
Taro case: US court rules in favour of Sun Pharma
15 July 2010
|
|
|
Sun Pharma gains 180-day marketing exclusivity for generic Exelon in the US
02 July 2010
|
|
|
Sun Pharma, Orion settle litigation over generic Stalevo and Comtan
22 June 2010
|
|
|
Sun Pharma's epilepsy drug granted US FDA approval
17 June 2010
|
|
|
Sun rejects Guggenheim's $215 million offer for Taro stake
03 June 2010
|
|
|
Sun Pharma net profit falls nearly 29 per cent to Rs898 crore
24 May 2010
|
|
|
US court bans Sun Pharma's generic equivalent of Sanofi's eloxatin
24 April 2010
|
|
|
Sun Pharmaceutical gets tentative US FDA approval for Alzheimer’s treatment
10 April 2010
|
|
|
Sun Pharma gets USFDA approval for generic Prometh syrup
18 March 2010
|
|
|
Sun fails to dislodge Taro directors at general body
01 January 2010
|
|
|
Glass Lewis supports Sun in Taro battle
23 December 2009
|
|
|
Templeton cold to Taro’s plea for protection against Sun
22 December 2009
|
|
|
Sun Pharma advises Taro shareholders against voting at AGM
18 December 2009
|
|
|
Taro again warns shareholders to stay away from Sun
12 December 2009
|
|
|
Templeton switches sides; backs Sun on Taro takeover
02 December 2009
|
|
|
Sun Pharma gets FDA nod for selling generic drug
27 November 2009
|
|
|
Sun Pharma earnings decline less-than-expected, Cipla earnings jump 82 per cent on forex gains
29 October 2009
|
|
|
Israeli drug firm Taro sues Sun Pharma in US
30 September 2009
|
|
|
Sun Pharma wins Gemzar patent motion against Eli Lilly in US court
18 August 2009
|
|
|
Sun Pharma settles Ethyol dispute with MedImmune
03 August 2009
|
|
|
Sun Pharma to license key escitalopram patent applications to Lundbeck
10 July 2009
|
|
|
After US FDA raid, Sun Pharma’s US subsidiary slashes half its workforce
07 July 2009
|
|
|
Sun Pharma puts up brave face after FDA crackdown
27 June 2009
|
|
|
US FDA seizes drugs from Sun Pharma subsidiary Caraco
26 June 2009
|
|
|
Pfizer brings patent infringement suits against Sun, Lupin, Wockhardt
06 May 2009
|
|
|
Taro asks Sun to raise bid; proposes shareholder referendum
06 January 2009
|
|
|
Sun offers to buy Taro shares at a premium
05 January 2009
|
|
|
Sun Pharma's US arm acquires Chattem
27 November 2008
|
|
|
Sun Pharma extends offer for Taro till 19 December
10 November 2008
|
|
|
Sun extends offer for Taro by a month as Israeli SC stays acquisition
04 September 2008
|
|
|
Sun Pharma wins Taro takeover case in Israel
27 August 2008
|
|
|
Sun Pharma gets US regulator's approval for Taro open offer
14 August 2008
|
|
|
Lupin Ltd, Sun Pharma and Dr Reddy's get US FDA approval for generic Depakote delayed-release tablets
31 July 2008
|
|
|
Sun set for a long battle for Taro
30 July 2008
|
|
|
Sun Pharma extends Taro tender offer
16 July 2008
|
|
|
Mark Mobius objects to Sun's acquisition of Taro
16 July 2008
|
|
|
Taro advises shareholders against Sun's open offer
11 July 2008
|
|
|
Sun goes ahead with Taro acquisition; files suit in US court
26 June 2008
|
|
|
Taro sues Sun Pharma again; alleges plan to block sale of Irish arm
20 June 2008
|
|
|
Taro selling Irish assets to thwart merger: Sun Pharma
06 June 2008
|
|
|
Sun Pharma warns of legal action against Taro for stalling merger
29 May 2008
|
|
|
Israel's Taro to terminate merger with Sun Pharmaceutical
28 May 2008
|
|
|
Sun Pharma gets US FDA approval to market generic Cerebyx
20 March 2008
|
|
|
USFDA approves Sun Pharmaceutical's generic cancer drug Ethyol in US markets
17 March 2008
|
|
|
USFDA grants tentative approval to Sun Pharma's generic anti-cancer injection Gemzar
07 March 2008
|
|
|
Sun Pharmaceutical buys Taro Pharma shares from Brandes
20 February 2008
|
|
|
Sun Pharma launches generic version of Wyeth's Protonix
30 January 2008
|
|
|
Sun Pharma announces settlement of litigation over generic Exelon
06 December 2007
|
|
|
US
FDA approves Sun Pharmaceutical''s Novartis-equivalent generic Exelon capsules
for US markets
24 October 2007
|
|
|
Ranbaxy
follows Sun Pharma in demerging R&D business
19 October 2007
|
|
|
US
FDA approves Sun Pharmaceutical'' version of Novartis''s Trileptal tablets for US
sales
10 October 2007
|
|
|
Sun
Pharmaceutical to acquire Taro Pharma for $454 million
21 May 2007
|
|
|
Eli
Lilly sues Sun Pharma over patent for cancer drug
02 April 2007
|
|
|
Sun Pharma to acquire companies in the US
24 January 2007
|
|
|
Sun Pharma Q4 net up 26 per cent
08 June 2006
|
|
|
Impressive results by Sun Pharma
31 October 2005
|
|
|
Sun
Pharma to buy manufacturing site in Hungary
11 August 2005
|
|
|
The rest didn''t do badly,
either
16 February 2005
|
|
|
Sun Pharma to issue $75 million FCCB
06 December 2004
|
|
|
Sun Pharma launches $225 million FCCB
19 November 2004
|
|
|
Sun Pharmaceuticals proposes share swap with Phlox Pharma
03 August 2004
|
|
|
Sun Pharma plants get US regulatory clearance
28 May 2004
|
|
|
Two Sun Pharma units gets USFDA approval
27 May 2004
|
|
|
1:1 bonus from Sun Pharma
24 April 2004
|
|
|
Sun Pharma increases holding in Caraco
16 March 2004
|
|
|
Sun
Pharma to increase holdings in Caraco to 60 per cent
09 February 2004
|
|
|
Sun Pharma logs healthy growth
03 February 2004
|
|
|
Sun
Pharma Q1 net, sales rise
28 July 2003
|
|
|
Sun
Pharma to invest Rs 25 cr in Jammu; posts good results
05 May 2003
|
|
|
Sun
Pharmaceuticals approves resolutions for split, buyback
21 December 2002
|
|
|
Sun
Pharma clocks 12% turnover, 14% PAT increase in Q2
29 October 2002
|
|
|
DCI
team clears Sun Pharma
research facility
18 September 2002
|
|
|
Sun Pharma
sales, profit up; dividend at 50%
01 June 2002
|
|
|
Sun Pharma
meet on merger with MJ Pharma
27 May 2002
|
|
|
Sun
Pharma commissions Dadra plant
30 March 2002
|
|
|
Sun to
commission Dadra plant
24 January 2002
|
|
|
Caraco gets FDA nod for a drug
09 January 2002
|
|
|
Explosion
at Sun Pharma lab
08 January 2002
|
|
|
Sildenafil citrate drug sales surge
05 December 2001
|
|
|
Sun Pharma
launches cure for smoking
14 August 2001
|
|
|
Will the ‘Sun’ rise on
Caraco Pharmaceuticals?
10 April 2001
|
|
|
Sun Pharma announces 1:500 share
swap for Pradeep Drugs
27 February 2001
|
|
|
Sun Pharma plans to take over
Pradeep Drugs
16 February 2001
|
